Your browser doesn't support javascript.
loading
Pharmacological inhibition of the SKP2/p300 signaling axis restricts castration-resistant prostate cancer.
Rezaeian, Abdol-Hossein; Phan, Liem Minh; Zhou, Xiaobo; Wei, Wenyi; Inuzuka, Hiroyuki.
Afiliação
  • Rezaeian AH; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, United States of America.
  • Phan LM; David Grant USAF Medical Center, Clinical Investigation Facility, 60th Medical Group, Travis Air Force Base, CA 94535, United States of America.
  • Zhou X; Brigham and Women's Hospital, Channing Division of Network Medicine, Boston, MA, United States of America.
  • Wei W; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, United States of America. Electronic address: wwei2@bidmc.harvard.edu.
  • Inuzuka H; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, United States of America; Brigham and Women's Hospital, Channing Division of Network Medicine, Boston, MA, United States of America.
Neoplasia ; 38: 100890, 2023 04.
Article em En | MEDLINE | ID: mdl-36871351
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias de Próstata Resistentes à Castração Limite: Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias de Próstata Resistentes à Castração Limite: Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article